ANTHIM DIN 02502895
Health Canada record
| Active ingredient(s) | OBILTOXAXIMAB 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | J06BC04 OBILTOXAXIMAB |
| Original market date | |
| Current status date | 13-Sep-2022 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23982 | 2020-07-30 | New Drug Submission (NDS) |